Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Rises By 100.8%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a large increase in short interest in December. As of December 15th, there was short interest totalling 26,100 shares, an increase of 100.8% from the November 30th total of 13,000 shares. Based on an average daily volume of 58,400 shares, the short-interest ratio is presently 0.4 days.

Cardio Diagnostics Stock Performance

NASDAQ CDIOW traded up $0.01 during mid-day trading on Friday, reaching $0.10. 23,626 shares of the stock were exchanged, compared to its average volume of 31,163. The business’s 50 day moving average is $0.05 and its 200-day moving average is $0.04. Cardio Diagnostics has a 1 year low of $0.02 and a 1 year high of $0.28.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.